When was SilcsBio founded?

SilcsBio was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is SilcsBio located?

SilcsBio is headquartered in Baltimore, United States.

How many employees does SilcsBio have?

As of Sep 30, 2026, the latest employee count at SilcsBio is 8.

Is SilcsBio a funded company?

SilcsBio is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 01, 2015.

When was the latest funding round of SilcsBio?

SilcsBio's latest funding was a $***** Grant (prize money) round on Mar 27, 2025, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $4.34B in funding in 2026 to date.

Where does SilcsBio rank among its competitors?

SilcsBio ranks 12th amongst 95 active competitors, of which 19 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Metaphore, which secured an undisclosed amount in Aug, 2026.

Who are the top competitors of SilcsBio?

SilcsBio's top competitors include Metaphore, Tahoe Bio and Panakeia. Among them, Metaphore secured the most recent funding round in August, 2026.

SilcsBio - 2026 Company Profile, Team, Funding & Competitors

Company Details

SilcsBio provides software and services for computer driven drug design. Its products include CGENFF to perform simulations on a system that contains a small organic molecule; SILCS, fragment-based drug design platform.

Website: silcsbio.com
Email ID: *****@silcsbio.com

Key Metrics

Founded Year

2012

Location

Baltimore, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Mar 27, 2025, $*****

Investors

NIH & 2 more

Ranked

12^th among 95 active competitors

Employee Count

8 as on Sep 30, 2026

Similar Companies

Metaphore & 116 more

View SilcsBio's full profile

SilcsBio has raised funding over 4 rounds. Its first funding round was on Mar 01, 2015. Its latest funding round was a Grant (prize money) round on Mar 27, 2025 for $*****. 1 investor participated in its latest round. SilcsBio has 3 institutional investors.

Here is the list of recent funding rounds of SilcsBio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 27, 2025	3327504	Grant (prize money)	1661934	6736993	3055137	9452628
Nov 16, 2021	3465988	Grant (prize money)	2900495	6875847	4514995	NIH
Mar 05, 2019	7514706	Grant (prize money)	4104512	4424347	7308450	HHS

Access funding benchmarks and valuations. Sign up today!

View details of SilcsBio's funding rounds and investors

The founders of SilcsBio are Ken Malone, Olgun Guvench and Alexander MacKerell.

Here are the details of SilcsBio's key team members:

Ken Malone: CEO & Co-Founder of SilcsBio.
Contact Info: 1 email address
Olgun Guvench: Co-Founder & Managing Director of SilcsBio.
Contact Info: 1 email address
Alexander MacKerell: Co-Founder of SilcsBio.
Contact Info: 1 email address

View details of SilcsBio's Founder profiles and Board Members

SilcsBio's employee count trend

SilcsBio has 8 employees as of Sep 26. Here is SilcsBio's employee count trend over the years:

Uncover SilcsBio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SilcsBio include Metaphore, Tahoe Bio and Panakeia. Here is the list of Top 10 competitors of SilcsBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Metaphore 2021, Cambridge (United States), Series C	Provider of machine language and computational platform for drug discovery	$50M	Flagship Pioneering, TOHO HOLDINGS & 1 others	61/100
2nd	Tahoe Bio 2022, San Francisco (United States), Series B	Developer of AI models for drug design using single-cell maps.	$30M	Amplify Partners, Wing Venture Capital & 6 others	59/100
3rd	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$4.04M	LocalGlobe, Entrepreneurs First & 6 others	59/100
4th	Algorithmic Biologics 2021, Bengaluru (India), Seed	Provider of software solutions for molecular diagnostics and discovery	$2.84M	Bharat Innovation Fund, Axilor Ventures & 3 others	48/100
5th	Synfini 2013, Menlo Park (United States), Series A	AI Drug Discovery \| Agile Chemistry Foundry \| Synfini	$8.9M	JSL Health Capital, Trust Ventures & 8 others	44/100
6th	StoneWise 2018, Haidian (China), Series B	Provider of a software solution solution for molecular modeling	$100M	Hillhouse, Linear Venture & 7 others	43/100
7th	Physiomics 2001, Oxford (United Kingdom), Public	Provider of virtual tumour technology based solutions for pre-clinical and clinical development	-	Shackleton Ventures	41/100
8th	QuanMol Tech 2022, Canada, Seed	Provider of AI based solutions in molecular designing	$3M	Plug and Play Tech Center, Hat-Trick Capital ... & 3 others	41/100
9th	Paradigm4 2009, Waltham (United States), Series A	Clinical data management and analytic tools	-	Kepha Partners, Sigma Prime Ventures & 4 others	39/100
10th	Valence Labs 2017, Montreal (Canada), Acquired	AI research engine focusing on advancing drug discovery through computational biology	$8.5M	Air Street Capital, Fifty Years & 17 others	38/100
12th	SilcsBio 2012, Baltimore (United States), Funding Raised	Provides software and services for computer driven drug design	-	NIH, HHS & 1 others	35/100